Preparation and immunogenic properties of a recombinant West Nile subunit vaccine.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Vaccine

• Publication date

  2007-01-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.VACCINE.2006.08.018PMID 16996661PMCID PMC1839850
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis.

  2007cited by this paper
• West Nile virus activity in Latin America and the Caribbean.

  2006cited by this paper
• Antibodies against West Nile Virus Nonstructural Protein NS1 Prevent Lethal Infection through Fc γ Receptor-Dependent and -Independent Mechanisms

  2006cited by this paper
• Protective and Therapeutic Capacity of Human Single-Chain Fv-Fc Fusion Proteins against West Nile Virus

  2005cited by this paper
• Variable Surface Epitopes in the Crystal Structure of Dengue Virus Type 3 Envelope Glycoprotein

  2005cited by this paper
• West nile virus encephalitis

  2005cited by this paper
• West Nile Virus

  2005cited by this paper
• A recombinant envelope protein vaccine against West Nile virus.

  2005cited by this paper
• Structure of the dengue virus envelope protein after membrane fusion

  2004cited by this paper
• Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge.

  2004cited by this paper
• Equine vaccine for West Nile virus.

  2003cited by this paper
• A Functional Epitope Determinant on Domain III of the Japanese Encephalitis Virus Envelope Protein Interacted with Neutralizing-Antibody Combining Sites

  2003cited by this paper
• A ligand-binding pocket in the dengue virus envelope glycoprotein

  2003cited by this paper
• Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults.

  2003cited by this paper
• Efficacy of Killed Virus Vaccine, Live Attenuated Chimeric Virus Vaccine, and Passive Immunization for Prevention of West Nile virus Encephalitis in Hamster Model

  2002cited by this paper
• Identification of Neutralizing Epitopes within Structural Domain III of the West Nile Virus Envelope Protein

  2002cited by this paper
• West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy

  2002cited by this paper
• West Nile virus encephalitis.

  2002cited by this paper
• West Nile virus vaccine.

  2001cited by this paper
• West Nile virus infection in the golden hamster (Mesocricetus auratus): a model for West Nile encephalitis.

  2001cited by this paper
• Immunization of Mice Against West Nile Virus with Recombinant Envelope Protein1

  2001cited by this paper
• Flavivirus DNA vaccines: current status and potential.

  2001cited by this paper
• Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey.

  2001cited by this paper
• West Nile virus: a reemerging global pathogen.

  2001cited by this paper
• Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999.

  2001cited by this paper
• Use of Recombinant Envelope Proteins for Serological Diagnosis of Dengue Virus Infection in an Immunochromatographic Assay

  2001cited by this paper
• Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells

  2001cited by this paper
• Flavivirus DNA Vaccines

  2001cited by this paper
• Clinical characteristics of the West Nile fever outbreak, Israel, 2000.

  2001cited by this paper
• Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines.

  2000cited by this paper
• A Live Attenuated West Nile Virus Strain as a Potential Veterinary Vaccine

  2000cited by this paper
• Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States.

  1999cited by this paper
• West Nile encephalitis epidemic in southeastern Romania.

  1998cited by this paper
• Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a.

  1996cited by this paper
• Update on cytokines.

  1996cited by this paper
• Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities.

  1995cited by this paper
• Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix.

  1995cited by this paper
• The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice.

  1993cited by this paper
• Regulated Expression Allows High Level Production and Secretion of HIV-1 gp120 Envelope Glycoprotein in Drosophila Schneider Cells

  1991cited by this paper
• Regulated expression at high copy number allows production of a growth-inhibitory oncogene product in Drosophila Schneider cells.

  1989cited by this paper
• TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

  1989cited by this paper
• Cell lines derived from late embryonic stages of Drosophila melanogaster.

  1972cited by this paper

• In silico post-hoc analysis of a clinically tested recombinant West Nile virus envelope protein vaccine

  2026cites this paper
• Humoral and cellular immune response to a single dose of a novel bivalent recombinant adenovirus-vector vaccine against West Nile virus and chikungunya virus in mice

  2025cites this paper
• Adenoviral Vectors Expressing Optimized preM/E Genes of WNV Deliver Long-Term Protection Against Lethal West Nile Virus Challenge

  2025cites this paper
• Process Intensification for Recombinant Marburg Virus Glycoprotein Production Using Drosophila S2 Cells

  2025cites this paper
• A Microsphere Immunoassay for the Quantitative Detection of Antigens in Cell Culture Supernatant.

  2024cites this paper
• The recombinant truncated envelope protein of West Nile virus adjuvanted with Alum/CpG induces potent humoral and T cell immunity in mice

  2023cites this paper
• Optimized Expression of Duck Tembusu Virus E Gene Delivered by a Vectored Duck Enteritis Virus In Vitro

  2019cites this paper
• A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human Primates

  2018cites this paper
• Vaccines Against West Nile Virus

  2018cites this paper
• Recombinant Zika Virus Subunits Are Immunogenic and Efficacious in Mice

  2018cites this paper
• Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells

  2018cites this paper
• A combination of TLR-4 agonist and saponin adjuvants increases antibody diversity and protective efficacy of a recombinant West Nile Virus antigen

  2018cites this paper
• Optimized expression of the antimicrobial protein Gloverin from Galleria mellonella using stably transformed Drosophila melanogaster S2 cells

  2017cites this paper
• Recent advances in human flavivirus vaccines.

  2017cites this paper
• Progress and Works in Progress: Update on Flavivirus Vaccine Development.

  2017cites this paper
• Process Optimization for Recombinant Protein Expression in Insect Cells

  2017cites this paper
• A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations

  2016cites this paper
• ELISA and Neutralization Methods to Measure Anti-West Nile Virus Antibody Responses.

  2016cites this paper
• Recent advances in the production of recombinant subunit vaccines in Pichia pastoris

  2016cites this paper
• West Nile Virus

  2016cites this paper
• An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection

  2016cites this paper
• Pathogenesis of West Nile Virus in Humans

  2015cites this paper
• Current trends in West Nile virus vaccine development

  2014cites this paper
• Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice.

  2014cites this paper
• Immunogenicity of a West Nile Virus DIII-Cholera Toxin A2/B Chimera after Intranasal Delivery

  2014cites this paper
• Technologies for the development of West Nile virus vaccines.

  2014cites this paper
• A Review of Vaccine Approaches for West Nile Virus

  2013cites this paper
• The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker.

  2013cites this paper
• Vaccination of Captive Nēnē (Branta sandvicensis) against West Nile Virus Using a Protein-based Vaccine (WN-80E)

  2013cites this paper
• New Trends in Antiviral Therapy of CNS Infections

  2013cites this paper
• Vaccines in Development against West Nile Virus

  2013cites this paper
• Rift Valley Fever Virus Glycoproteins, Key to Entry and Control

  2013cites this paper
• The use of Drosophila S2 cells in R&D and bioprocessing

  2013cites this paper
• 1 Encephalitic Flaviviruses

  2012cites this paper
• Journal of Experimental and Clinical Medicine Deneysel ve Klinik Tip Dergisi

  2012cites this paper
• Research advances in plant-made flavivirus antigens.

  2012cites this paper
• Viral encephalitis: current treatments and future perspectives.

  2012cites this paper
• Differentiation of West Nile Virus-Infected Animals from Vaccinated Animals by Competitive ELISA Using Monoclonal Antibodies Against Non-Structural Protein 1

  2012cites this paper
• Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥ 50 years of age.

  2012cites this paper
• Protective immunity to Japanese encephalitis virus associated with anti-NS1 antibodies in a mouse model

  2012cites this paper
• Towards a West Nile Virus Vaccine

  2012cites this paper
• Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus.

  2011cites this paper
• Phase II, randomized, double-blind, placebo-controlled, multicenter study to investigate the immunogenicity and safety of a West Nile virus vaccine in healthy adults.

  2011cites this paper
• Tick-borne Encephalitis Vaccines.

  2011cites this paper
• gilt meiner Familie und besonders meinen Eltern , die mir mein Studium ermöglichten und auf deren

  2011cites this paper
• CHAPTER 76 – Japanese Encephalitis, West Nile, and Other Flavivirus Infections

  2011cites this paper
• Recombinant West Nile virus envelope protein E and domain III expressed in insect larvae protects mice against West Nile disease.

  2011cites this paper
• A DNA-based West Nile virus replicon elicits humoral and cellular immune responses in mice.

  2011cites this paper
• A normal life in science.

  2010cites this paper
• West Nile Virus: Characteristics of an African Virus Adapting to the Third Millennium World

  2010cites this paper
• Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate.

  2010cites this paper
• West Nile virus.

  2010cites this paper
• Flavitrack analysis of the structure and function of West Nile non-structural proteins

  2010cites this paper
• Nile Encephalitis Westas Immunization Vectors Protect against TLR 9-Targeted Biodegradable Nanoparticles Data

  2010cites this paper
• Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge.

  2010cites this paper
• Development and evaluation of a formalin-inactivated West Nile Virus vaccine (WN-VAX) for a human vaccine candidate.

  2010cites this paper
• The development of flavivirus vaccines

  2010cites this paper
• Fine-specificity and functional quality of the antibody response in mice to whole inactivated West Nile virus and recombinant subunit antigens

  2010influential citation
• TLR9-Targeted Biodegradable Nanoparticles as Immunization Vectors Protect against West Nile Encephalitis

  2010cites this paper
• A normal life in science

  2010cites this paper
• West Nile Encephalitis as Immunization Vectors Protect against TLR9-Targeted Biodegradable Nanoparticles

  2010cites this paper
• Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII.

  2009cites this paper
• A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells.

  2009cites this paper
• Oral and Parenteral Immunization of Chickens (Gallus gallus) Against West Nile Virus with Recombinant Envelope Protein

  2009cites this paper
• Immunogenicity and Protective Efficacy of a Recombinant Subunit West Nile Virus Vaccine in Rhesus Monkeys

  2009influential citation
• Search for correlates of protection

  2009cites this paper
• Vaccine Development Against West Nile Virus

  2009cites this paper
• A global perspective on the epidemiology of West Nile virus.

  2008cites this paper
• Interferon and Interferon-Induced Chemokine Expression Is Associated with Control of Acute Viremia in West Nile Virus-Infected Blood Donors

  2008cites this paper
• Protective immunity of E. coli-synthesized NS1 protein of Japanese encephalitis virus

  2008cites this paper
• Third-generation flavivirus vaccines based on single-cycle, encapsidation-defective viruses.

  2008cites this paper
• Evaluation of the efficacy of a recombinant subunit West Nile vaccine in Syrian golden hamsters.

  2008cites this paper
• Protective efficacy of a recombinant subunit West Nile virus vaccine in domestic geese (Anser anser).

  2008cites this paper
• Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine.

  2007cites this paper
• Expression of particulate-form of Japanese encephalitis virus envelope protein in a stably transfected Drosophila cell line

  2007cites this paper
• Antibody Recognition of Cell Surface-Associated NS1 Triggers Fc- (cid:2) Receptor-Mediated Phagocytosis and Clearance of West Nile Virus-Infected Cells (cid:1)

  2007cites this paper
• Antibody Recognition of Cell Surface-Associated NS1 Triggers Fc-γ Receptor-Mediated Phagocytosis and Clearance of West Nile Virus-Infected Cells

  2007cites this paper
• Efficacy and durability of a recombinant subunit West Nile vaccine candidate in protecting hamsters from West Nile encephalitis.

  2007cites this paper
• Induction of Epitope-Specific Neutralizing Antibodies against

  2007cites this paper
• Induction of Epitope-Specific Neutralizing Antibodies against West Nile Virus

  2007cites this paper
• Complex Adenovirus-Mediated Expression of West Nile Virus C, PreM, E, and NS1 Proteins Induces both Humoral and Cellular Immune Responses

  2007cites this paper
• Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development

  2007cites this paper
• Japanese Encephalitis and West Nile and Other Flavivirus Infections

  2006cites this paper
• Tlr9-targeted Biodegradable Nanoparticles

  year unknowncites this paper